NASDAQ: IRWD
Ironwood Pharmaceuticals Inc Stock

$0.73-0.02 (-2.67%)
Updated Apr 17, 2025
IRWD Price
$0.73
Fair Value Price
N/A
Market Cap
$117.64M
52 Week Low
$0.59
52 Week High
$8.45
P/E
72.7x
P/B
-0.39x
P/S
2.01x
PEG
0.38x
Dividend Yield
N/A
Revenue
$351.41M
Earnings
$880.00k
Gross Margin
100%
Operating Margin
27.95%
Profit Margin
0.3%
Debt to Equity
-2.17
Operating Cash Flow
$104M
Beta
0.54
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A

IRWD Overview

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine IRWD's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Pharmaceutical

Industry Rating
B
IRWD
Ranked
#14 of 54

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$7.36A
$24.65A
$13.76A
View Top Pharmaceutical Stocks

Be the first to know about important IRWD news, forecast changes, insider trades & much more!

IRWD News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IRWD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IRWD ($0.73) is trading above its intrinsic value of $0.71, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IRWD is poor value based on its earnings relative to its share price (72.7x), compared to the US market average (27.98x)
P/E vs Market Valuation
IRWD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more IRWD due diligence checks available for Premium users.

Valuation

IRWD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
72.7x
Industry
20.48x
Market
27.98x
IRWD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IRWD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

IRWD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-0.39x
Industry
1.99x

IRWD price to earnings growth (PEG)

For valuing profitable companies with growth potential

IRWD is good value based... subscribe to Premium to read more.
PEG Value Valuation

IRWD's financial health

Profit margin

Revenue
$90.5M
Net Income
$2.3M
Profit Margin
2.5%
IRWD's Earnings (EBIT) of $98.23M... subscribe to Premium to read more.
Interest Coverage Financials
IRWD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$350.9M
Liabilities
$652.2M
Debt to equity
-2.17
IRWD's short-term assets ($182.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IRWD's long-term liabilities ($613.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IRWD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IRWD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$15.2M
Investing
$0.0
Financing
-$14.9M
IRWD's operating cash flow ($103.55M)... subscribe to Premium to read more.
Debt Coverage Financials

IRWD vs Pharmaceutical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
IRWDB$117.64M-3.07%72.70x-0.39x
OGIC$134.99M+2.88%-2.73x0.60x
BIOAD$138.74M+3.20%-0.58x0.43x
OPTN$92.36M+0.11%-4.33x-2.29x
DERMC$144.40M+0.64%-8.68x7.20x

Ironwood Pharmaceuticals Stock FAQ

What is Ironwood Pharmaceuticals's quote symbol?

(NASDAQ: IRWD) Ironwood Pharmaceuticals trades on the NASDAQ under the ticker symbol IRWD. Ironwood Pharmaceuticals stock quotes can also be displayed as NASDAQ: IRWD.

If you're new to stock investing, here's how to buy Ironwood Pharmaceuticals stock.

What is the 52 week high and low for Ironwood Pharmaceuticals (NASDAQ: IRWD)?

(NASDAQ: IRWD) Ironwood Pharmaceuticals's 52-week high was $8.45, and its 52-week low was $0.59. It is currently -91.4% from its 52-week high and 23.01% from its 52-week low.

How much is Ironwood Pharmaceuticals stock worth today?

(NASDAQ: IRWD) Ironwood Pharmaceuticals currently has 161,809,432 outstanding shares. With Ironwood Pharmaceuticals stock trading at $0.73 per share, the total value of Ironwood Pharmaceuticals stock (market capitalization) is $117.64M.

Ironwood Pharmaceuticals stock was originally listed at a price of $11.65 in Feb 3, 2010. If you had invested in Ironwood Pharmaceuticals stock at $11.65, your return over the last 15 years would have been -93.76%, for an annualized return of -16.88% (not including any dividends or dividend reinvestments).

How much is Ironwood Pharmaceuticals's stock price per share?

(NASDAQ: IRWD) Ironwood Pharmaceuticals stock price per share is $0.73 today (as of Apr 17, 2025).

What is Ironwood Pharmaceuticals's Market Cap?

(NASDAQ: IRWD) Ironwood Pharmaceuticals's market cap is $117.64M, as of Apr 21, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ironwood Pharmaceuticals's market cap is calculated by multiplying IRWD's current stock price of $0.73 by IRWD's total outstanding shares of 161,809,432.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.